Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C D Blanke

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Current Oncology (Toronto, Ont.)|July 17, 2020
Tyrosine kinase inhibitors significantly improved survival outcomes in patients with metastatic gastrointestinal stromal tumour: a multi-institutional cohort studyA Deruchie Tan, K Willemsma, A MacNeill, et al.
Investigational New Drugs|April 9, 2001
A phase I study of vitamin E, 5-fluorouracil and leucovorin for advanced malignanciesC D Blanke, M Stipanov, J Morrow, et al.
British Journal of Cancer|September 12, 2013
Higher capecitabine AUC in elderly patients with advanced colorectal cancer (SWOGS0030)S G Louie, B Ely, H-J Lenz, et al.
British Journal of Cancer|January 16, 2014
S0941: a phase 2 SWOG study of sorafenib and erlotinib in patients with advanced gallbladder carcinoma or cholangiocarcinomaA B El-Khoueiry, C Rankin, A B Siegel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2002
A double-blind placebo-controlled randomized phase III trial of 5-fluorouracil and leucovorin, plus or minus trimetrexate, in previously untreated patients with advanced colorectal cancerC D Blanke, J Shultz, J Cox, et al.
American Journal of Surgery|June 12, 1999
Transcatheter arterial chemoembolization as primary treatment for hepatocellular carcinomaD M Rose, W C Chapman, A T Brockenbrough, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 26, 2013
Assessment of HER2 gene amplification in adenocarcinomas of the stomach or gastroesophageal junction in the INT-0116/SWOG9008 clinical trialM A Gordon, H M Gundacker, J Benedetti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 17, 2026
DART (NCI/SWOG S1609): Comprehensive Final Results from Dual Checkpoint Inhibition with CTLA-4 and PD-1 Blockade in Rare CancersS P Patel, M Othus, Y K Chae, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Current Oncology (Toronto, Ont.)|July 17, 2020
Tyrosine kinase inhibitors significantly improved survival outcomes in patients with metastatic gastrointestinal stromal tumour: a multi-institutional cohort studyA Deruchie Tan, K Willemsma, A MacNeill, et al.
Investigational New Drugs|April 9, 2001
A phase I study of vitamin E, 5-fluorouracil and leucovorin for advanced malignanciesC D Blanke, M Stipanov, J Morrow, et al.
British Journal of Cancer|September 12, 2013
Higher capecitabine AUC in elderly patients with advanced colorectal cancer (SWOGS0030)S G Louie, B Ely, H-J Lenz, et al.
British Journal of Cancer|January 16, 2014
S0941: a phase 2 SWOG study of sorafenib and erlotinib in patients with advanced gallbladder carcinoma or cholangiocarcinomaA B El-Khoueiry, C Rankin, A B Siegel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2002
A double-blind placebo-controlled randomized phase III trial of 5-fluorouracil and leucovorin, plus or minus trimetrexate, in previously untreated patients with advanced colorectal cancerC D Blanke, J Shultz, J Cox, et al.
American Journal of Surgery|June 12, 1999
Transcatheter arterial chemoembolization as primary treatment for hepatocellular carcinomaD M Rose, W C Chapman, A T Brockenbrough, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 26, 2013
Assessment of HER2 gene amplification in adenocarcinomas of the stomach or gastroesophageal junction in the INT-0116/SWOG9008 clinical trialM A Gordon, H M Gundacker, J Benedetti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 17, 2026
DART (NCI/SWOG S1609): Comprehensive Final Results from Dual Checkpoint Inhibition with CTLA-4 and PD-1 Blockade in Rare CancersS P Patel, M Othus, Y K Chae, et al.
Pageof 3